SCHEMBL24127583

SCHEMBL24127583

Brc1ccc2c(c1)c1ccccc1n2-c1cccc(C(c2ccccc2)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ TSPO P30536 3/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ RAD52 P43351 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NOTUM Q6P988 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ LIG1 P18858 1/20 0.33
▸ DNM1 Q05193 2/20 0.33
▸ PPARG P37231 2/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ DNMT1 P26358 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ FOLH1 Q04609 1/20 0.31
▸ ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27119985 0.90 KDM4E (0.43) L3MBTL1KDM4EATMTSPOMEN1
SCHEMBL24127579 0.89 L3MBTL1 (0.49) L3MBTL1KDM4EATMTSPOMEN1
SCHEMBL24127595 0.88 KDM4E (0.52) L3MBTL1KDM4EATMNOTUMALDH1A1
SCHEMBL24127605 0.88 KDM4E (0.52) L3MBTL1KDM4EATMNOTUMALDH1A1
SCHEMBL25799362 0.88 L3MBTL1 (0.59) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL24127584 0.88 L3MBTL1 (0.59) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL25826291 0.86 KDM4E (0.41) L3MBTL1KDM4EATMMEN1KMT2A
SCHEMBL17228100 0.86 L3MBTL1 (0.49) L3MBTL1KDM4EATMTSPOMEN1
SCHEMBL14910947 0.85 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOMEN1
SCHEMBL14910746 0.85 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210399229-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210399229-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CRY1, LEF1, ODC1 L3MBTL1 2130/4885KDM4E 2293/4885ATM 4351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback